133 related articles for article (PubMed ID: 35525312)
1. Dequalinium chloride is an antagonists of α7 nicotinic acetylcholine receptors.
Belanger-Coast MG; Zhang M; Bugay V; Gutierrez RA; Gregory SR; Yu W; Brenner R
Eur J Pharmacol; 2022 Jun; 925():175000. PubMed ID: 35525312
[TBL] [Abstract][Full Text] [Related]
2. Physiological concentrations of choline activate native alpha7-containing nicotinic acetylcholine receptors in the presence of PNU-120596 [1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)-urea].
Gusev AG; Uteshev VV
J Pharmacol Exp Ther; 2010 Feb; 332(2):588-98. PubMed ID: 19923442
[TBL] [Abstract][Full Text] [Related]
3. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological investigation of the effect of structurally different bispyridinium non-oxime compounds on human α7-nicotinic acetylcholine receptor activity-An in vitro structure-activity analysis.
Scheffel C; Niessen KV; Rappenglück S; Wanner KT; Thiermann H; Worek F; Seeger T
Toxicol Lett; 2018 Sep; 293():157-166. PubMed ID: 29191791
[TBL] [Abstract][Full Text] [Related]
5. Sazetidine-A Activates and Desensitizes Native α7 Nicotinic Acetylcholine Receptors.
Brown JL; Wonnacott S
Neurochem Res; 2015 Oct; 40(10):2047-54. PubMed ID: 24728867
[TBL] [Abstract][Full Text] [Related]
6. N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists.
Criado M; Mulet J; Sala F; Sala S; Colmena I; Gandía L; Bautista-Aguilera OM; Samadi A; Chioua M; Marco-Contelles J
ACS Chem Neurosci; 2016 Aug; 7(8):1157-65. PubMed ID: 27254782
[TBL] [Abstract][Full Text] [Related]
7. Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
Innocent N; Livingstone PD; Hone A; Kimura A; Young T; Whiteaker P; McIntosh JM; Wonnacott S
J Pharmacol Exp Ther; 2008 Nov; 327(2):529-37. PubMed ID: 18664588
[TBL] [Abstract][Full Text] [Related]
8. Functional properties of alpha7 nicotinic acetylcholine receptors co-expressed with RIC-3 in a stable recombinant CHO-K1 cell line.
Roncarati R; Seredenina T; Jow B; Jow F; Papini S; Kramer A; Bothmann H; Dunlop J; Terstappen GC
Assay Drug Dev Technol; 2008 Apr; 6(2):181-93. PubMed ID: 18471073
[TBL] [Abstract][Full Text] [Related]
9. Multiple modes of α7 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents.
Peng C; Kimbrell MR; Tian C; Pack TF; Crooks PA; Fifer EK; Papke RL
Mol Pharmacol; 2013 Sep; 84(3):459-75. PubMed ID: 23839567
[TBL] [Abstract][Full Text] [Related]
10. Counteracting desensitization of human α7-nicotinic acetylcholine receptors with bispyridinium compounds as an approach against organophosphorus poisoning.
Scheffel C; Niessen KV; Rappenglück S; Wanner KT; Thiermann H; Worek F; Seeger T
Toxicol Lett; 2018 Sep; 293():149-156. PubMed ID: 29248576
[TBL] [Abstract][Full Text] [Related]
11. Bis-Quinolinium Cyclophane Blockers of SK Potassium Channels Are Antagonists of M3 Muscarinic Acetylcholine Receptors.
Bugay V; Wallace DJ; Wang B; Salinas I; Chapparo AP; Smith HR; Dube PH; Brooks EG; Berg KA; Brenner R
Front Pharmacol; 2020; 11():552211. PubMed ID: 33041794
[TBL] [Abstract][Full Text] [Related]
12. PNU-120596, a positive allosteric modulator of mammalian α7 nicotinic acetylcholine receptor, is a negative modulator of ligand-gated chloride-selective channels of the gastropod Lymnaea stagnalis.
Vulfius CA; Lebedev DS; Kryukova EV; Kudryavtsev DS; Kolbaev SN; Utkin YN; Tsetlin VI
J Neurochem; 2020 Nov; 155(3):274-284. PubMed ID: 32248535
[TBL] [Abstract][Full Text] [Related]
13. Allosterically Potentiated
Miller DR; Khoshbouei H; Garai S; Cantwell LN; Stokes C; Thakur G; Papke RL
Mol Pharmacol; 2020 Dec; 98(6):695-709. PubMed ID: 33020143
[TBL] [Abstract][Full Text] [Related]
14. α7 nicotinic acetylcholine receptors control cytochrome c release from isolated mitochondria through kinase-mediated pathways.
Gergalova G; Lykhmus O; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2014 Apr; 49():26-31. PubMed ID: 24412630
[TBL] [Abstract][Full Text] [Related]
15. Characterization of compounds on nicotinic acetylcholine receptor alpha7 channels using higher throughput electrophysiology.
Friis S; Mathes C; Sunesen M; Bowlby MR; Dunlop J
J Neurosci Methods; 2009 Feb; 177(1):142-8. PubMed ID: 19000713
[TBL] [Abstract][Full Text] [Related]
16. Somatic integration of single ion channel responses of α7 nicotinic acetylcholine receptors enhanced by PNU-120596.
Uteshev VV
PLoS One; 2012; 7(3):e32951. PubMed ID: 22479351
[TBL] [Abstract][Full Text] [Related]
17. Studies on the role of alpha 7 nicotinic acetylcholine receptors in K562 cell proliferation and signaling.
Önder Narin G; Aydın B; Cabadak H
Mol Biol Rep; 2021 Jun; 48(6):5045-5055. PubMed ID: 34143396
[TBL] [Abstract][Full Text] [Related]
18. Mode of action of the positive modulator PNU-120596 on α7 nicotinic acetylcholine receptors.
Szabo AK; Pesti K; Mike A; Vizi ES
Neuropharmacology; 2014 Jun; 81():42-54. PubMed ID: 24486377
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of αM-conotoxin SIIID, a reversible human α7 nicotinic acetylcholine receptor antagonist.
Wang H; Li Y; Yang M; Zhou M
Toxicon; 2022 Apr; 210():141-147. PubMed ID: 35255330
[TBL] [Abstract][Full Text] [Related]
20. Kinetic properties and open probability of α7 nicotinic acetylcholine receptors.
Pesti K; Szabo AK; Mike A; Vizi ES
Neuropharmacology; 2014 Jun; 81():101-15. PubMed ID: 24486379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
